Skip to main content
Download PDF

Correction: Immunosenescence: a key player in cancer development

Journal of Hematology & Oncology volume 18, Article number: 25 (2025) Cite this article

The Original Article was published on 10 November 2020

Correction: Journal of Hematology & Oncology (2020) 13:151

https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13045-020-00986-z

In the ahead-mentioned sentence in the original article, ‘KLRG1' was incorrectly written as ‘NKG2C’, leading to an inaccurate statement.

The authors regret this oversight and wish to clarify that the corrected sentence should instead read:

“It should be noted that, in the process of immunosenescence, the activating receptor expression of natural killer (NK) cell markers NKP30, NKP46, etc., is reduced, while the inhibitory receptor expression of KIR, KLRG1, etc., is increased”.

Author information

Author notes

  1. Jingyao Lian, Ying Yue, and Weina Yu contributed equally to this work

Authors and Affiliations

  1. Biotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, 1 Jianshe East Road, Zhengzhou, 450052, Henan, China

    Jingyao Lian, Ying Yue, Weina Yu & Yi Zhang

  2. State Key Laboratory of Esophageal Cancer Prevention and Treatment, Zhengzhou, 450052, Henan, China

    Jingyao Lian, Ying Yue, Weina Yu & Yi Zhang

  3. Clinical Laboratory, Henan Medical College Hospital Workers, Zhengzhou, 450000, Henan, China

    Ying Yue

Authors
  1. Jingyao Lian
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. Ying Yue
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. Weina Yu
    View author publications

    You can also search for this author inPubMed Google Scholar

  4. Yi Zhang
    View author publications

    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence to Yi Zhang.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The online version of the original article can be found at https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13045-020-00986-z

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lian, J., Yue, Y., Yu, W. et al. Correction: Immunosenescence: a key player in cancer development. J Hematol Oncol 18, 25 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13045-025-01682-6

Download citation

  • Published:

  • DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13045-025-01682-6

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us